215 related articles for article (PubMed ID: 34415656)
1. The role of gut microbiota in hepatitis B disease progression and treatment.
Chen B; Huang H; Pan CQ
J Viral Hepat; 2022 Feb; 29(2):94-106. PubMed ID: 34415656
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
Kang Y; Cai Y
J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
5. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
Li X; Wu S; Du Y; Yang L; Li Y; Hong B
Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
[TBL] [Abstract][Full Text] [Related]
6. Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection.
Sun X; Pan CQ; Xing H
Hepatol Int; 2021 Oct; 15(5):1053-1067. PubMed ID: 34596865
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice.
Zhu Q; Xia P; Zhou X; Li X; Guo W; Zhu B; Zheng X; Wang B; Yang D; Wang J
Front Cell Infect Microbiol; 2019; 9():377. PubMed ID: 31750262
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
Wang J; Wang Y; Zhang X; Liu J; Zhang Q; Zhao Y; Peng J; Feng Q; Dai J; Sun S; Zhao Y; Zhao L; Zhang Y; Hu Y; Zhang M
Front Microbiol; 2017; 8():2222. PubMed ID: 29180991
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between gut microbiota and liver biochemical indicators in patients with chronic hepatitis B].
Zhao Z; Qin S; Wang L; Li L; Liu Y; Deng L; Zou Z
Sheng Wu Gong Cheng Xue Bao; 2021 Jan; 37(1):301-311. PubMed ID: 33501810
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes.
Li YN; Kang NL; Jiang JJ; Zhu YY; Liu YR; Zeng DW; Wang F
World J Gastroenterol; 2022 Sep; 28(35):5188-5202. PubMed ID: 36188719
[TBL] [Abstract][Full Text] [Related]
12. Modulation of bile acid profile by gut microbiota in chronic hepatitis B.
Wang X; Chen L; Wang H; Cai W; Xie Q
J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions.
Li YG; Yu ZJ; Li A; Ren ZG
World J Gastroenterol; 2022 Jul; 28(28):3555-3572. PubMed ID: 36161048
[TBL] [Abstract][Full Text] [Related]
15. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases.
Liu J; Yang D; Wang X; Asare PT; Zhang Q; Na L; Shao L
Front Cell Infect Microbiol; 2022; 12():774335. PubMed ID: 35444959
[TBL] [Abstract][Full Text] [Related]
17. Alcohol, liver disease and the gut microbiota.
Bajaj JS
Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
19. Microbiota and viral hepatitis: State of the art of a complex matter.
Milosevic I; Russo E; Vujovic A; Barac A; Stevanovic O; Gitto S; Amedei A
World J Gastroenterol; 2021 Sep; 27(33):5488-5501. PubMed ID: 34588747
[TBL] [Abstract][Full Text] [Related]
20. Human gut microbiota from hepatitis B virus-infected individuals is associated with reduced triglyceride level in mice: faecal transplantation study.
Kim HN; Cheong HS; Kim B; Sohn W; Cho YK; Kwon MJ; Kim J; Song Y; Joo EJ
Microbes Infect; 2024; 26(3):105281. PubMed ID: 38128750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
